Status | Study |
Active, not recruiting |
Study Name: A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) Condition: Alveolar Soft-part Sarcoma Date: 2011-04-11 Interventions: Drug: Cediranib 30mg once dail |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Date: 2010-06-29 Interventions: Drug: Gamma-Secretase Inhibitor RO4929097 |
Recruiting |
Study Name: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma Condition: Sarcoma, Alveolar Soft Part Date: 2009-07-18 Interventions: Drug: AZD2171 Cediranib (AZD2171), a VEGF/KIT tyrosine kinase inhibitor, has demonstrated antitumor acti |
Completed |
Study Name: Phase 2 Study in Patients With MiT Tumors Condition: Renal Cell Carcinoma (RCC) Alveolar Soft Part Sarcoma (ASPS) Date: 2007-11-12 Interventions: Drug: ARQ 197 360 mg administered twice daily until disease progression or other discontinuation criteri |
Active, not recruiting |
Study Name: Trial of Dasatinib in Advanced Sarcomas Condition: Rhabdomyosarcoma Malignant Peripheral Nerve Sheath Tumors Date: 2007-04-20 Interventions: Drug: Dasatinib oral agent, continuous dosing, Cycles = 28 days |
Completed |
Study Name: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas Condition: Chondrosarcomas Alveolar Soft Part Sarcomas Date: 2006-11-17 Interventions: Drug: Perifosine Perifosine is |
Not yet recruiting |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition: Adult Alveolar Soft-part Sarcoma Adult Angiosarcoma Date: 2006-06-28 Interventions: Drug: doxorubicin hydrochloride |
Completed |
Study Name: Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research Condition: Alveolar Soft Part Sarcoma Sarcoma Date: 2006-06-19 |
Active, not recruiting |
Study Name: Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma Condition: Sarcoma, Clear Cell Sarcoma, Alveolar Soft Part Date: 2005-11-23 Interventions: Biological: GVAX 4 vaccines every two weeks |
Completed |
Study Name: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Condition: Adult Alveolar Soft-part Sarcoma Adult Angiosarcoma Date: 2005-06-02 Interventions: Drug: romidepsin DEP is administered at a dose of 13 mg/m2 as a 4-hour intravenous infusion in the outpa |